Solventum Corp | SOLV - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Align Technology USD 4.23B 83.03M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Cencora USD 3.4B 1.49B 2026-03
Dexcom USD 2.62B 335.5M 2026-06
Insulet USD 1.42B 119.6M 2026-06
Solventum Corp USD 4.8B 169M 2026-06
West Pharmaceutical Services USD 2.99B 200K 2026-06
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06